Clinical Trials Directory

Trials / Sponsors / Harbour BioMed (Guangzhou) Co. Ltd.

Harbour BioMed (Guangzhou) Co. Ltd.

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
UnknownA Trial of HBM9378 in Healthy Chinese Subjects
Asthma
Phase 12022-08-26
UnknownEvaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
Myasthenia Gravis
Phase 32022-06-30
Active Not RecruitingHBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
Solid Tumors, Neuroendocrine Tumors, CRC
Phase 12021-12-28
UnknownA Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab i
Solid Tumors
Phase 12021-12-20
CompletedEvaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patie
Myasthenia Gravis
Phase 32021-09-25
UnknownA Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease
Thyroid Ophthalmopathy
Phase 2 / Phase 32021-09-22
UnknownA Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 An
Solid Tumor
Phase 12021-06-14
UnknownStudy Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Tori
Solid Tumors
Phase 12021-02-28
UnknownA Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
Dry Eye
Phase 32021-02-24
CompletedA Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
Myasthenia Gravis
Phase 22020-07-23
UnknownA Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP
Primary Immune Thrombocytopenic Purpura
Phase 2 / Phase 32020-07-21
CompletedA Study of HBM9161 in NMOSD Patients
NMO Spectrum Disorder
Phase 12020-03-31
CompletedA Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers
Healthy Chinese Volunteers
Phase 12019-06-03
CompletedA Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
Dry Eye
Phase 22019-03-22